WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 51.00
+1.36 (2.74%)
Aug 21, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 209.29 billion as of August 21, 2026. Its market cap has increased by 68.88% in one year.
Market Cap
209.29B
Enterprise Value
201.68B
Revenue
24.25B
Ranking
n/a
PE Ratio
39.49
Stock Price
51.00
ChartMarket Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 209.29B, an increase of 553.24%. That is a compound annual growth rate of 22.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 209.29B | 61.04% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 335.97B |
| Innovent Biologics | 176.18B |
| Sichuan Kelun-Biotech Biopharmaceutical | 127.40B |
| Sino Biopharmaceutical | 85.31B |
| Akeso | 82.26B |
| Genscript Biotech | 72.95B |
| RemeGen | 71.58B |
| Biocytogen Pharmaceuticals (Beijing) | 58.22B |